Studies presented at AMP Global conference in Berlin reaffirm powerful analytical performance and ease of use for the world’s first complete Sample to Insight NGS solution Hilden, Germany, April 3, 2017 – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced further validation of the GeneReader NGS System with the publication of five new… Read article →
The inaugural AMP Global Congress on Molecular Pathology, hosted by the Association for Medical Pathologists (AMP), is the event of the year for molecular pathology, diagnostic technologies and research and clinical applications. AMP Global 2017 is the perfect event for QIAGEN to remind and educate the market about our broad menu of Sample to Insight… Read article →
Find out how QIAGEN and NeuMoDx are bringing the simplicity of clinical chemistry to molecular diagnostics. Visit b… https://t.co/3QbI5utB9c, Do you know which pathogen is causing your patient's symptoms? With panels for 20+ pathogens causing respiratory o… https://t.co/zUpP9YxybD, Remember - reserve your spot today for the special webinar with Dr. Mairiead MacLennan on improving efficiency in t… https://t.co/AplGWYT5b2, Just one more day to register for the webinar with Dr. Mairiead MacLennan on improving efficiency in the modern mic… https://t.co/boZDQeMA9g, Visit us today at booth P3 for one more opportunity to see QIAstat-Dx and the NeuMoDx 96 in action. We look forward… https://t.co/N7OJmqnUKg, 